Merck
Merck Serono won’t give up on cancer vaccine
September 26, 2013Sales and Marketing Merck, Merck Serono, Stimuvax
Merck Serono’s once failed lung cancer vaccine treatment Stimuvax has been given a second chance as the German firm begins …
MSD’s sugammadex knocked back by FDA – again
September 25, 2013Research and Development, Sales and Marketing FDA, MSD, Merck, Sugammedex
AstraZeneca pays Merck for cancer drug
September 11, 2013Sales and Marketing AstraZeneca, Cancer, Merck, WEE1
AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …
Green light at Merck facility boosts varicella vaccine supplies
September 9, 2013Manufacturing and Production Merck, Taylor, varicella
Prospects for Merck & Co’s vaccines for shingles and chickenpox have been lifted by approval of additional bulk manufacturing capacity …
NHS shingles vaccine rolls out for people in their 70s
September 2, 2013Sales and Marketing Merck, NHS, Zostavax, shingles
The NHS will introduce a nationwide shingles vaccination scheme this week aimed at people in their 70s. Merck’s Zostavax will …
Merck told to make $1 billion in cuts
August 22, 2013Sales and Marketing Leerink Swann, MSD, Merck, Odanacatib, sugammadex
Merck to shut New Jersey campus, shedding 113 jobs
August 8, 2013Manufacturing and Production Jobs, Merck, Schering-Plough, cuts
Merck & Co has followed through with an earlier threat to close down its manufacturing operations at Kenilworth, New Jersey. …
Merck, Hedinger first suppliers certified under excipient scheme
August 1, 2013Manufacturing and Production Merck, Merck KGaA
Merck KGaA’s EMD Millipore unit and fellow German firm Hedinger have become the first two excipient suppliers to be certified …
Merck sees sales dip
July 31, 2013Sales and Marketing Merck, Q2, Singulair, sales
A catastrophic decline in sales of asthma medicine Singulair is among the key reasons why Merck’s pharma revenue fell 12% …
MSD cleared by PMCPA
July 23, 2013Medical Communications, Sales and Marketing ABPI, MSD, Merck, PMCPA, code
Merck Sharp Dohme has been found not guilty of breaching two clauses in the ABPI Code of Practice – including …
MSD takes Januvia rap
July 9, 2013Medical Communications, Sales and Marketing Januvia, MSD, Merck, PMCPA
Merck Sharp & Dohme has been censured by the PMCPA for failing to uphold standards in the way it promoted …
Aspen buys Merck facility and products in $1 billion deal
July 1, 2013Manufacturing and Production MSD, Merck, Oss, aspen
Africa’s largest drugmaker Aspen Pharmacare has agreed to buy a manufacturing facility owned by Merck & Co, plus a portfolio …
Nine fined in EU pay-for-delay deals
June 20, 2013Manufacturing and Production, Sales and Marketing EU, Lundbeck, Merck, Ranbaxy
Nine pharma firms have been handed hefty fines by the European Commission over allegations that they willingly blocked generic versions …
FDA experts recommend Merck sleep pill
May 24, 2013Research and Development, Sales and Marketing FDA, Merck, insomnia, suvorexant
Merck received welcome news this week from the FDA after one of the US regulator’s expert groups voted to approve …
Hurel appoints Schering-Plough executive to its Board
May 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing Hurel, Merck, Schering-Plough
Pre-clinical products firm Hurel has appointed Dr James MacDonald to the company’s Board of directors. MacDonald is the former executive …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
